| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Cepeprubart | SelK-2 | Phase 2 Clinical | Selexys | Asthma; Pulmonary Disease, Chronic Obstructive; Venous Thromboembolism | 詳細 |
| Leiolizumab | AbGn 168H2; AbGn-268; AbGn-168H2; ALTB-268 | Phase 2 Clinical | Altrubio Inc | Arthritis, Psoriatic; Colitis, Ulcerative | 詳細 |
| Neihulizumab | AbGn-168; AbGn-168H; ALTB-168 | Phase 1 Clinical | Altrubio Inc | Arthritis, Psoriatic; Colitis, Ulcerative; Graft vs Host Disease; Plaque psoriasis; Psoriasis | 詳細 |
| SSGJ-617 | SSGJ-617; SSGJ617; 61X; VTX-0811; 617 | Phase 1 Clinical | Verseau Therapeutics Inc | Solid tumours | 詳細 |